Two Sigma Advisers’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.92M Sell
59,742
-129,700
-68% -$6.33M 0.01% 958
2025
Q1
$9.65M Sell
189,442
-171,000
-47% -$8.71M 0.02% 540
2024
Q4
$16.3M Sell
360,442
-69,400
-16% -$3.13M 0.04% 374
2024
Q3
$15.9M Buy
429,842
+40,300
+10% +$1.5M 0.04% 367
2024
Q2
$11.9M Sell
389,542
-3,700
-0.9% -$113K 0.03% 489
2024
Q1
$11.4M Buy
393,242
+203,400
+107% +$5.92M 0.03% 494
2023
Q4
$5.23M Sell
189,842
-14,300
-7% -$394K 0.01% 787
2023
Q3
$4.57M Sell
204,142
-82,300
-29% -$1.84M 0.01% 784
2023
Q2
$11.6M Sell
286,442
-42,200
-13% -$1.72M 0.03% 445
2023
Q1
$15.9M Buy
328,642
+9,700
+3% +$470K 0.04% 396
2022
Q4
$12.2M Buy
318,942
+45,900
+17% +$1.75M 0.03% 460
2022
Q3
$13.7M Buy
+273,042
New +$13.7M 0.04% 413
2022
Q1
Sell
-5,500
Closed -$219K 2872
2021
Q4
$219K Buy
+5,500
New +$219K ﹤0.01% 2256
2021
Q1
Sell
-7,000
Closed -$427K 2687
2020
Q4
$427K Sell
7,000
-41,400
-86% -$2.53M ﹤0.01% 1923
2020
Q3
$2.26M Sell
48,400
-213,842
-82% -$10M 0.01% 1095
2020
Q2
$13.3M Sell
262,242
-43,900
-14% -$2.23M 0.04% 450
2020
Q1
$13.7M Buy
306,142
+41,400
+16% +$1.85M 0.05% 385
2019
Q4
$12.7M Buy
+264,742
New +$12.7M 0.03% 515
2019
Q3
Sell
-7,500
Closed -$338K 2360
2019
Q2
$338K Sell
7,500
-48,300
-87% -$2.18M ﹤0.01% 1967
2019
Q1
$2.1M Sell
55,800
-11,300
-17% -$425K 0.01% 1199
2018
Q4
$2.3M Sell
67,100
-100,600
-60% -$3.45M 0.01% 1116
2018
Q3
$7.88M Sell
167,700
-222,500
-57% -$10.5M 0.02% 655
2018
Q2
$13.2M Buy
390,200
+50,600
+15% +$1.71M 0.04% 503
2018
Q1
$9.19M Buy
+339,600
New +$9.19M 0.02% 614
2016
Q3
Sell
-161,100
Closed -$1.13M 2289
2016
Q2
$1.13M Sell
161,100
-64,700
-29% -$454K 0.01% 1106
2016
Q1
$1.45M Buy
+225,800
New +$1.45M 0.01% 946
2015
Q3
Sell
-6,400
Closed -$308K 1943
2015
Q2
$308K Sell
6,400
-7,800
-55% -$375K ﹤0.01% 1604
2015
Q1
$864K Buy
14,200
+9,200
+184% +$560K 0.01% 1138
2014
Q4
$259K Buy
+5,000
New +$259K ﹤0.01% 1773